Use of naloxone nasal spray 4 mg in the community setting: a survey of use by community organizations.

Abstract

OBJECTIVE Naloxone hydrochloride, an opioid antagonist, has been approved as a concentrated 4 mg dose intranasal formulation for the emergency treatment of known or suspected opioid overdose. This new formulation is easier to use and contains a higher dose of naloxone compared with earlier, unapproved kits. A survey of first responders and community-based… (More)
DOI: 10.1080/03007995.2017.1334637

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics